COVID19



Yourgene Genomic Services providing COVID-19 services to MHC’s new Boots partnership

Aptamer Group and Mologic extend collaboration to CE mark Aptamer Group's SARS-CoV-2 rapid antigen test

With the effects of the pandemic continuing to cause many deaths, it is right that pharma companies have put IP on the back burner for now, but it shouldn’t be forgotten.

The new scheme aims to help businesses affected by Covid-19 and can be used for any legitimate business purpose, including managing cashflow, investment and growth. It is designed to appeal ...

University of Bradford professor is leading UK-wide awareness campaign

A thank you from one of our customers for our support during the pandemic.

This bulletin aims to keep the life sciences sector up to date on the latest guidance and during the Coronavirus (COVID-19) outbreak, providing you with information from Government to help y...

The Challenge of managing a workforce in the midst of a global pandemic.

Sixty-million doses of the Novavax vaccine are set to be manufactured in Stockton-on-Tees by FUJIFILM Diosynth Biotechnologies (FDB) with the National Horizons Centre to play a major role de...

Scientists at the Alderley Park Lighthouse Lab in Cheshire have revealed the speed and scale at which the new variant of the COVID virus is spreading through communities across the country.

Genomics has provided us with a new armoury for tackling pandemics, enabling us to respond faster and with more accuracy to COVID-19.

Yourgene (AIM: YGEN), the international molecular diagnostics group, announces that following the Company’s statement on 24 December 2020, regarding the new virus strain (VUI-202012/01 SAR...